# FDA 483 - AbbVie Inc. - June 18, 2024

Source: https://www.globalkeysolutions.net/records/483/abbvie-inc/1218dc0c-087e-44ff-8404-4d75a2dd55ed

> FDA 483 for AbbVie Inc. on June 18, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AbbVie Inc.
- Inspection Date: 2024-06-18
- Product Type: drugs
- Office Name: FDA District Office — Chicago, Illinois

## Related Documents

- [483 - 2024-06-18](https://www.globalkeysolutions.net/records/483/abbvie-inc/7e512946-7c93-4d23-9562-94c9c7dc0048)
- [CRL - Unknown Date](https://www.globalkeysolutions.net/records/crl/abbvie-inc/c35438c0-ba63-48cc-9220-b887563775b5)

## Related Officers

- [Program Expert ](https://www.globalkeysolutions.net/people/michele-l-obert/7ac8155e-cc5a-4e89-a885-c68ce69adb4e)
- [Michele L. Glendenning](https://www.globalkeysolutions.net/people/michele-l-glendenning/a3c23a43-634c-4140-807b-c17fbc03bb00)

Company: https://www.globalkeysolutions.net/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad

Office: https://www.globalkeysolutions.net/offices/fda-district-office-chicago-illinois/94f7fb7a-46c6-4ae9-b8f3-fb9a79a8a1da